Ignite Creation Date:
2024-05-06 @ 2:42 AM
Last Modification Date:
2024-10-26 @ 11:22 AM
Study NCT ID:
NCT02105493
Status:
COMPLETED
Last Update Posted:
2014-04-07
First Post:
2014-02-19
Brief Title:
Nitroglycerin Prevents Radial Artery Occlusion
Sponsor:
National Cardiovascular Center Harapan Kita Hospital Indonesia
Organization:
National Cardiovascular Center Harapan Kita Hospital Indonesia
Study Overview
Official Title:
A Novel Approach to Reduce Radial Artery Occlusion After Trans-Radial Catheterization Post-ProceduralPre-Hemostasis Intra-Arterial Nitroglycerin
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NORAO
Brief Summary:
Trans-radial approach TRA has becoming popular and widely adopted over the last decade However radial artery occlusion RAO continues to be one of the limitation of trans-radial access and potentially limits the radial artery as an access site in the future Several strategies have been used to decrease the incidence of RAO including the use of anticoagulation maintenance of patency during hemostasis or shortening the duration of compression Currently there is no data whether vasoactive pharmacological therapy such as nitroglycerin administered intra-arterially at the end of the procedure may reduce the incidence of RAO It is hypothesized that the addition of nitroglycerin nitric oxide donor at the end of a TRA procedure may reduce the incidence of RAO
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None